New drug combo shows promise in targeting RAS-mutant multiple myeloma

The combination of a drug and a protein fragment prevents the growth of blood cancer cells, a new study in mice shows.

Characterizing the concentration and binding affinity of WT–induced antibodies against the Omicron subvariant BA.1

A recent study characterized the concentration and binding affinity of antibodies induced by SARS-CoV-2 WT strain against the Omicron subvariant BA.1.

July 25, 2023

Homelessness Tied to Worse Cancer Outcomes Among Veterans

Homelessness was associated with diagnosis of colorectal cancer at later stages and increased rates of all-cause mortality for those with lung and colorectal cancers, according

December 22, 2023

Ayr Wellness Q2 Revenue Declines 1% Sequentially

AYR Wellness Reports Second Quarter 2023 Results Revenue up 18% Y/Y to $116.7 Million, Excluding Discontinued Operations Company Delivers Record Adjusted EBITDA1 of $29.4 Million,

August 17, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.